These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 35784919

  • 1. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X.
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [Abstract] [Full Text] [Related]

  • 2. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y, Song Q, Xu F, Zhou Y, Zuo X, Zhang Z.
    Front Genet; 2022; 13():823443. PubMed ID: 35368686
    [Abstract] [Full Text] [Related]

  • 3. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.
    Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y.
    Transl Cancer Res; 2024 Jun 30; 13(6):2799-2811. PubMed ID: 38988942
    [Abstract] [Full Text] [Related]

  • 4. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
    Xu F, Cai D, Liu S, He K, Chen J, Qu L, Chong T, Li X, Ren B.
    Am J Cancer Res; 2023 Jun 30; 13(2):538-568. PubMed ID: 36895966
    [Abstract] [Full Text] [Related]

  • 5. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL.
    Front Genet; 2022 Jun 30; 13():930446. PubMed ID: 36110218
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X.
    Front Genet; 2022 Jun 30; 13():929035. PubMed ID: 36081998
    [Abstract] [Full Text] [Related]

  • 7. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 30; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 8. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 9. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P.
    J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203
    [Abstract] [Full Text] [Related]

  • 10. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
    Gao Y, Ren J, Chen K, Guan G.
    J Gastrointest Oncol; 2024 Feb 29; 15(1):203-219. PubMed ID: 38482248
    [Abstract] [Full Text] [Related]

  • 11. Prognostic model and ceRNA network of m7G- and radiosensitivity-related genes in hepatocellular carcinoma.
    Liu M, Zhu M, Huang Y, Wu J, Peng Z, Liang Y.
    Heliyon; 2024 May 15; 10(9):e29925. PubMed ID: 38707306
    [Abstract] [Full Text] [Related]

  • 12. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma.
    Regmi P, He ZQ, Lia T, Paudyal A, Li FY.
    Front Genet; 2022 May 15; 13():918983. PubMed ID: 35734429
    [Abstract] [Full Text] [Related]

  • 13. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W, Xu F, Zhao M, Zhang S.
    BMC Cancer; 2021 Oct 29; 21(1):1160. PubMed ID: 34715817
    [Abstract] [Full Text] [Related]

  • 14. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X.
    Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958
    [Abstract] [Full Text] [Related]

  • 15. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J, Liang Y, Gu JJ, Huang Y, Wang B.
    Front Genet; 2022 May 08; 13():991162. PubMed ID: 36353118
    [Abstract] [Full Text] [Related]

  • 16. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
    Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y.
    Front Oncol; 2022 May 08; 12():934928. PubMed ID: 35992788
    [Abstract] [Full Text] [Related]

  • 17. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
    Dai D, Zhuang H, Shu M, Chen L, Long C, Wu H, Chen B.
    Heliyon; 2024 Apr 30; 10(8):e29326. PubMed ID: 38628712
    [Abstract] [Full Text] [Related]

  • 18. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
    Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS.
    PLoS One; 2023 Apr 30; 18(8):e0289552. PubMed ID: 37535570
    [Abstract] [Full Text] [Related]

  • 19. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.
    Yue Y, Tao J, An D, Shi L.
    J Gene Med; 2024 Jan 30; 26(1):e3611. PubMed ID: 37847055
    [Abstract] [Full Text] [Related]

  • 20. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
    Liu Y, Jiang B, Lin C, Zhu W, Chen D, Sheng Y, Lou Z, Ji Z, Wu C, Wu M.
    Front Oncol; 2022 Jan 30; 12():1055605. PubMed ID: 36761423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.